A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home Archive for category "Therapies" (Page 7)
formats

St. Jude Starts Trial of Accent MRI Pacemaker and Tendril MRI Lead

Today St. Jude announced the first implant in its Accent MRI(R) Pacemaker and Tendril MRI(R) Lead IDE Study (MRI Study). The ultimate goal of the study is to determine if patients with these devices can safely undergo full-body, high resolution Magnetic Resonance Imaging (MRI) scans to better accommodate their medical needs. The investigational Accent MRI

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Starts Trial of Accent MRI Pacemaker and Tendril MRI Lead  comments 
formats

Digikon’s History

In response to my post “A Challenge to History Buffs:  Who Was Digikon?“, Paolo Pagani sent me the following message: “Digikon was in the years 1977-1985 the brand name product in Italy by Biotec Biomedical Technologies of Bologna – ITALY. Pacemakers were a Digikon O.E.M. production for the trading company of Milan Italy KONTRON already

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Digikon’s History  comments 
formats

Monash University in Australia Starts Test of Direct-to-Brain Visual Prosthesis Chips

Engineers from the Monash Vision Group (MVG) have begun trialling the ASICs for a direct-to-brain visual prosthesis that is expected to enter human clinical trials in 2014. The prosthesis will consist of a tiny camera mounted into a pair of glasses, which acts as the retina; a pocket processor, which takes the electronic information from

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Monash University in Australia Starts Test of Direct-to-Brain Visual Prosthesis Chips  comments 
formats

John Hopkins Researcher Develops New Early-Warning Seizures Detector with Low False-Positive Rate

Johns Hopkins’ Sridevi V. Sarma, an assistant professor of biomedical engineering, has devised new seizure detection software that, in early testing, significantly cuts the number of unneeded brain-stimulation therapy that an epilepsy patient would receive. According to Sarma, “These devices use algorithms—a series of mathematical steps—to figure out when to administer the treatment,” Sarma said. “They’re

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on John Hopkins Researcher Develops New Early-Warning Seizures Detector with Low False-Positive Rate  comments 
formats

St. Jude Seeks Retraction of Heart Rhythm Journal Manuscript by Dr. Robert Hauser Regarding the Failure of Riata and Riata ST Implantable Cardioverter-Defibrillator Leads

St. Jude announced it is seeking a retraction of the manuscript accepted for publication in the Heart Rhythm Journal by Dr. Robert Hauser, et al., titled, “Deaths Caused by the Failure of Riata and Riata ST Implantable Cardioverter-Defibrillator Leads.” St. Jude claims that the research performed by Hauser undercounted and excluded MAUDE data reports for

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Seeks Retraction of Heart Rhythm Journal Manuscript by Dr. Robert Hauser Regarding the Failure of Riata and Riata ST Implantable Cardioverter-Defibrillator Leads  comments 
formats

St. Jude Warns Physicians of Potential Problem with QuickSite and QuickFlex LV CRT Leads

St. Jude announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of QuickSite® and QuickFlex® Left-Ventricular Leads, used to connect Cardiac Resynchronization Therapy devices to the heart. The announcement noted that there have been no reports of patient injury or loss of therapy due to externalized conductors in

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Warns Physicians of Potential Problem with QuickSite and QuickFlex LV CRT Leads  comments 
formats

St. Jude Medical Announces Clinical Benefits of Quadripolar CRT Pacing at ACC

St. Jude Medical announced that clinical findings on quadripolar pacing will be presented at the 61st Annual Scientific Sessions of the American College of Cardiology (ACC, Chicago, March 24-27 2012). According to St. Jude’s announcement, quadripolar pacing allows physicians the ability to use multisite left-ventricular (LV) pacing.  Studies that examined the role of multisite pacing in improving hemodynamics and

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Medical Announces Clinical Benefits of Quadripolar CRT Pacing at ACC  comments 
formats

Boston Scientific to Acquire Cameron Health for $150M Up-Front + $150M Upon FDA Approval

Boston Scientific announced the exercise of its option to acquire Cameron Health.  Cameron Health developed the world’s first and only commercially-available subcutaneous implantable cardioverter defibrillator – the S-ICD® System that I blogged about a few weeks ago. The agreement calls for an upfront payment of $150 million, payable upon transaction closing, an additional potential $150

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific to Acquire Cameron Health for $150M Up-Front + $150M Upon FDA Approval  comments 
formats

Medtronic Receives CE Mark for CapSure Sense MRI™ SureScan® Pacing Leads

Medtronic today announced the receipt of CE Mark and launch of the CapSure Sense MRI™ SureScan® pacing leads, which are approved for use during MRI procedures.  The newly approved leads are the smallest MR–Conditional leads available in the world with a 5.3 French isodiametric lead body.  The new leads are passive-fixation leads.  Previously approved Medtronic MR–Conditional leads

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
2 Comments  comments 
formats

iPacemaker Implantable Pacemaker/ICD Database for the iPhone

My friend and colleague Dr. Irit Yaniv alerted me to this iPhone app that was just released.  It is an implantable pacemaker and defibrillator database that, according to its author, displays up to 70 parameters for each model, includes battery and longevity data, and links directly to product manuals.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on iPacemaker Implantable Pacemaker/ICD Database for the iPhone  comments 
formats

The Australian Pacemaker: Telectronics (1965-1995)

In 1965, Australian medical device pioneer Noel Gray established Telectronics – Australia’s first manufacturing facility for producing pacemakers that were designed in-house.  Telectronics was an innovative developer, achieving some major successes in the early cardiac pacing field, for example, Telectronics’ leads allowed narrowing the pacing pulse to its current nominal of 0.5 milliseconds; encapsulating the pacemaker in titanium

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
3 Comments  comments 
formats

VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology

  On January 17, 2012, VeriTeQ Acquisition Corporation of Delray Beach, FL announced that it acquired the VeriChip implantable RFID technology and its related Health Link personal health record from PositiveID Corporation.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology  comments 
formats

DF-4 Connectors for Implantable Cardioverter Defibrillators Enter Use in the US

The DF-4 Connector was recently introduced by a joint group of CRM companies, physicians, and regulatory agencies as a way of easing the implant of ICDs by reducing defibrillation connections from three to one and by minimizing the number of set screws.  Prior to the development of the DF-4, traditional high-voltage connector systems required up to three connections.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on DF-4 Connectors for Implantable Cardioverter Defibrillators Enter Use in the US  comments 
formats

Remon Medical’s Implantable Pulmonary Pressure Sensor (1997-2007)

Remon Medical Technologies, Ltd. was founded in 1997 in Caesarea, Israel to develop implantable, wireless pressure sensors. Remon developed an implantable hemodynamic monitor, which allowed on-demand, non-invasive, leadless self-monitoring of pulmonary artery pressure by the patient at home. ImPressure devices were placed in the pulmonary artery, and transmitted pressure readings to a hand-held monitor.  It was hoped that the

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
1 Comment  comments 
formats

SMSI® Implantable Glucose Sensor

Sensors for Medicine and Science, Inc. (SMSI)  of Germantown, MD was founded in 1997 to develop chemical sensing technologies based on fluorescence sensing. SMSI® is now developing an implantable glucose sensor that is designed to automatically measure interstitial glucose every few minutes. The sensor implant communicates wirelessly with a small external reader, allowing it to track

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on SMSI® Implantable Glucose Sensor  comments